← Back to Search

Cancer Vaccine

Peanut Consumption for High Blood Pressure

N/A

Recruiting

Led By Robert M Brothers, PhD

Research Sponsored by The University of Texas at Arlington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline & following 8 weeks of daily peanut consumption

Awards & highlights

Study Summary

"This trial aims to study how eating more peanuts each day affects the brain and body health of BL individuals."

Who is the study for?

This trial is for men and women aged 18-50 who identify as white or black, with at least one parent of the same race/ethnicity. It's not for those with peanut allergies, in hypertensive crisis, pregnant or breastfeeding women, people allergic to spandex/lycra, or anyone who donated a lot of blood recently.Check my eligibility

What is being tested?

The study is looking at how eating more peanuts daily affects brain function and heart health in Black individuals. Participants will be asked to include peanuts in their diet regularly to see if there are any benefits.See study design

What are the potential side effects?

Since this trial involves adding peanuts to the diet, potential side effects may include digestive discomfort or allergic reactions for those who might have undiscovered sensitivities to peanuts.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline & following 8 weeks of daily peanut consumption

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline & following 8 weeks of daily peanut consumption

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline & following 8 weeks of daily peanut consumption for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Arterial stiffness

Endothelial Function

Lipid profile (Total-C, LDL-C, VLDL-C, HDL-C, TG)

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Peanut ConsumptionExperimental Treatment1 Intervention

Peanuts are rich in polyphenols and also have anti-inflammatory and antioxidant properties.

Group II: Non-peanut consumptionActive Control1 Intervention

The non-peanut consumption will simply not be consuming any additional supplements in their diet

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The University of Texas at ArlingtonLead Sponsor

43 Previous Clinical Trials

4,878 Total Patients Enrolled

Robert M Brothers, PhDPrincipal InvestigatorUniversity of Texas at Arlington

5 Previous Clinical Trials

179 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which individuals meet the eligibility criteria to be considered for inclusion in this research study?

"Enrollment in this medical research study requires individuals aged between 18 and 50 with a confirmed diagnosis of cardiovascular disease. The trial aims to enroll approximately 60 eligible participants."

Answered by AI

Is the enrollment phase for this investigation currently ongoing?

"As per clinicaltrials.gov, this investigation is presently in search of suitable participants. It was initially listed on September 1st, 2022 and last updated on March 12th, 2024."

Answered by AI

What is the current number of individuals undergoing treatment in this medical study?

"Indeed, the details on clinicaltrials.gov confirm that this investigation is presently seeking volunteers. The trial's initial posting was on September 1st, 2022, and its latest update occurred on March 12th, 2024. Enrollment aims to reach a total of 60 participants at one designated location."

Answered by AI